For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety ...

Guillain-Barre Syndrome (GBS) is a rare neurological disorder in which the body’s immune system mistakenly attacks the ...

Hansa Biopharma AB (HNSBF) reports a robust 35% increase in IDEFIRIX sales and expands its European market presence, despite facing revenue fluctuations and operating losses.

GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been ...

Management projected strong growth for 2025, driven by expanded reimbursement in key European markets such as Spain and Italy and the expected completion of the post-approval efficacy study (PAES).

Guillain-Barré Syndrome (GBS) poses a diagnostic challenge due to its misleading symptoms, the lack of a definitive test, and ...

In what is being reported as the first case of Guillain-Barré Syndrome (GBS) in Telangana, a 25-year-old woman hailing from Siddipet district has been admitted to a private hospital in Hyderabad.

Guillain-Barre Syndrome in Pune: With an increase in Guillain-Barré Syndrome (GBS) cases in Pune, Maharashtra, the city's Municipal Corporation has issued health guidelines to safeguard citizens ...

A woman from Siddipet in Telangana was admitted to a private hospital in Hyderabad with symptoms indicative of Guillain-Barré Syndrome (GBS). Her condition was said to be critical. Listen to Story ...

Pune is currently experiencing a surge in Guillain-Barré Syndrome (GBS) cases, a rare but severe neurological condition affecting the peripheral nervous system. On Sunday, the Maharashtra health ...

Following the recent outbreak of Guillain-Barre Syndrome (GBS), a rare neurological condition in Pune, the Health Department has included Intravenous Immunoglobulin (IVIG) therapy for the ...

The number of suspected cases of Guillain-Barre Syndrome (GBS), a rare nerve disorder, in Pune and some other districts of Maharashtra has risen to 130, health department officials have said. Two ...